Tag Archives: G551D

How To Get Kalydeco Funded In Canada

Posted on 2014-06-19 by admin

So – finally! – after Health Canada approved Kalydeco in November 2012 for use in Canada by CF patients aged six years and older who have the specific G551D mutation, it now appears this brilliant new medication will soon be … Continue reading →

Posted in Cystic Fibrosis | Tagged , , , , , , , | Leave a comment

Good News About Kalydeco From Nova Scotia

Posted on 2013-12-12 by admin

Today we finally (!) had some good news regarding the funding of Kalydeco. In an interview with CBC’s Elizabeth Chiu, Nova Scotia Health Minister Leo Glavine stood up for CF patients, like Carys Nurse and Tim Vallillee, and committed to … Continue reading →

Posted in Cystic Fibrosis | Tagged , , , , , , , | Leave a comment

Nothing to Celebrate

Posted on 2013-11-30 by admin

One Year Anniversary of Canadian Approval for KALYDECO Goes by Without Public Access TORONTO – Canadians with cystic Fibrosis (CF) have been living with unequal access to treatment for a full year now as KALYDECO a life-saving treatment for this … Continue reading →

Posted in Cystic Fibrosis | Tagged , , , , | Leave a comment

Access To KALYDECO™

Posted on 2013-11-29 by admin

The Cystic Fibrosis gene was discovered in Canada in 1989 at the Hospital for Sick Children. Now, some 20 years later, we have the first medicine to result from that discovery: KALYDECO™. Also known by its generic name, ivacaftor, it … Continue reading →

Posted in Cystic Fibrosis | Tagged , , , , | Leave a comment